Medicated IUS

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: An intrauterine system (IUS) containing a candidate progesterone agonist - likely etonogestrel, the synthetic progestin that is in Implanon/Nexplanon. Dosage under study.

Updated date: July 21, 2016

Vertical Tabs

Status

Project Phase: Late Development

Project Stage: Phase II

Status Details:
  • Phase II studies were completed in July 2011 to test different quantities of etonogestrel (38mg, 61mg, 72mg) and different thicknesses of the reservoir’s membrane (350 μm, 140 μm, and 50 μm), respectively. This work was done under authority of the European Medicines Agency.

Download Product Report